Our study provides a basis for further investigation of the role of NBPF1 in regulating the immune microenvironment and offers novel ideas for developing anti-NBPF1 immunotherapy for patients with ACC. This evidence concerns the gene NBPF1 and adrenal cortex carcinoma.